Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for Fortini returned no results
Showing 31 to 45 of 96 results for forming

  1. Cognitive behavioural therapy (CBT) to support withdrawal from benzodiazepines: What is the most effective model of CBT, including timing of CBT, to support withdrawal from benzodiazepines?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  2. Service models for withdrawal interventions: What service models are most effective in supporting withdrawal from medicines associated with dependence and withdrawal symptoms?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  3. Psychological interventions to support withdrawal: What are the most effective psychological interventions to support withdrawal and help people cope with withdrawal symptoms?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  4. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  5. Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies or interventions to aid withdrawal of gabapentinoids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  6. Multicomponent withdrawal interventions: What are the key components of an effective multicomponent intervention to support dose reduction during withdrawal of opioids?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  7. Information for family members or carers: What information and support are needed by family members or carers of people having treatment with an opioid, benzodiazepine, Z‑drug, antidepressant or gabapentinoid?

    recommendation for research, see the rationale section on starting a dependence-forming medicine or antidepressant. Full details of the...

    Research recommendation
    Published
    11 May 2022

  8. Aids to support withdrawal: What is the effectiveness of equipment, technologies, practical aids and medicine formulations in supporting people to manage dose reductions, compared with usual practice?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  9. Converting to a medicine with a different half‑life to aid withdrawal: What is the clinical and cost effectiveness of converting to medicines with a longer half‑life to aid withdrawal from benzodiazepines or antidepressants?

    recommendation for research, see the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  10. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    the rationale section on making decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  11. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    the rationale section on making decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of...

    Research recommendation
    Published
    11 May 2022

  12. Photodynamic therapy for early-stage oesophageal cancer (IPG200)

    Evidence-based recommendations on photodynamic therapy for early-stage oesophageal cancer. This involves injecting a photosensitising agent into the tumour which is then activated by a light to destroy the tumour cells.

    Interventional procedures guidance
    Published
    13 December 2006
    View recommendations

    Sections for IPG200

  13. Extracorporeal carbon dioxide removal for acute respiratory failure (IPG776)

    Evidence-based recommendations on extracorporeal carbon dioxide removal for acute respiratory failure. This involves taking blood out of the circulatory system and passing it across a synthetic membrane that allows some of the carbon dioxide in the blood to be removed. The blood is then returned to the circulatory system.

    Interventional procedures guidance
    Published
    15 November 2023
    View recommendations

    Sections for IPG776

  14. Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction (IPG457)

    Evidence-based recommendations on insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction. This involves making the titanium implants specially to fit the person using a model of their face.

    Interventional procedures guidance
    Published
    23 July 2013
    View recommendations

    Sections for IPG457

  15. What factors are necessary for an effective and cost effective community-wide approach to obesity prevention?

    benefits of voluntary versus imposed partnerships; and best practice in forming and sustaining partnerships. - At what point is...

    Research recommendation
    Published
    9 June 2015